Concepedia

Sarah Wolf

SW

Statistics

Publications

3

Citations

81

H-Index

3

Active since

2017

Affiliations

Austrian Institute for Health Technology Assessment GmbH(Current)

Sarah Wolf is an author at Austrian Institute for Health Technology Assessment GmbH specializing in oncology, oncology pharmacotherapy, and cancer pharmacology.

ORCID

Publications per year

2017–2021

3

Publications

3

Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit

N. Grössmann, Joseph C. Del Paggio, Sarah Wolf et al. · European Journal of Cancer · 2017 · 41 citations · Full text

, , +9

Twelve years of European cancer drug approval—a systematic investigation of the ‘magnitude of clinical benefit’

N. Grössmann, Sarah Wolf, E. Rothschedl et al. · ESMO Open · 2021 · 23 citations · Full text

, , +12

A cost‐effectiveness analysis of <i>Erwinia</i> asparaginase therapy in children with acute lymphoblastic leukemia

Robin Q.H. Kloos, Raphaële R. L. van Litsenburg, Sarah Wolf et al. · Pediatric Blood & Cancer · 2018 · 17 citations · Full text

, , +11

1–3 of 3